'flight-fight' or 'conservation-withdrawal' systems as biological defences. Thus disease is more apt to appear at such time of disruption and increased vulnerability. But we think it important to emphasize again that periods of giving up are not always followed by disease and all episodes of disease do not occur in a setting of a giving-up reaction. Indeed, until mediating mechanisms and their interaction with processes involved in the pathogenesis of various diseases are worked out, it is prudent to assume that in some instances the interaction may have no influence on the course of the disease, in some instances it may modify the clinical picture without influencing the course, and in some instances it may even influence the course favourably. Elucidation of these interrelationships is a task for the future. Winkle (1962a) reported the excretion of 3,4-dimethoxyphenylethylamine (DMPE) in the urine of schizophrenics. This finding together with other recent experimental work has provided evidence that schizophrenia may be associated with an abnormality of the transmethylating mechanisms of the body (e.g. Pollin et al. 1961 , Brune & Himwich 1962 , Smythies 1963 , Greiner & Nicolson 1965 . Later reports concerning DMPE excretion have been contradictory and have resulted in considerable confusion.
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The importance of transmethylation reactions in the metabolism of normal body constituents was not appreciated until the late 1950s when Axelrod & Tomchick (1958) and Axelrod (1961) described the isolation of both 0-methyl transferase and N-methyl transferase. Since then, methylation reactions have been shown to be intimately connected with the biosynthesis and metabolism of a variety of compounds (Axelrod 1965) , and it has become apparent that these enzymes are of major importance in the metabolism of noradrenaline and adrenaline.
Before anything was known of the enzymes involved in transmethylation, Osmond & Smythies (1952) had proposed that in schizophrenia a compound might be formed which resembled in chemical structure both adrenaline and mescaline and which had the physiological properties of mescaline. Harley-Mason (1952) suggested that such a compound might arise during the methylation reaction which occurs in the final stage of the biogenesis of adrenaline. This hypothesis was extended in 1963 by Smythies, who postulated that a more generalized disturbance of the methylation reactions may occur in schizophrenia resulting in the formation of abnormally methylated metabolites of catechols and indoles related to known psychotomimetic compounds.
The interest in Osmond & Smythies' hypothesis had, by this time, been heightened following Friedhoff & Van Winkle's account of the isolation of DMPE from the urine of 15 out of 19 schizophrenics and its absence from the urine of 14 normal subjects (Friedhoff & Van Winkle 1962a) . This substance was extracted from the urine using chloroform and was separated from other materials in the extract by two-way paper chromatography. The substance isolated Proc. R. Soc. Med. Volume 60 June 1967 had chromatographic characteristics identical with DMPE, namely the same Rf values in various solvent systems and identical staining reactions when located with ninhydrin followed by a modified Ehrlich's reagent.
When the criteria laid down by Friedhoff & Van Winkle (1963) were fulfilled they claimed that a pink spot was only given by substituted Pphenylethylamino compounds and, as examples, included in their investigations tyramine, dopamine, 4-hydroxy-3-methoxy-p-phenylethylamine, 3,4-dimethoxy-p-phenylethylamine and mescaline (and they distinguished these from the unsubstituted compounds ,-phenylethylamine and phenylalanine which gave a more orange spot).
However, although these compounds all give a pink colour they can be distinguished from each other by their different Rf values in various chromatographic systems (Friedhoff & Van Winkle 1962b) . It is by this criterion, in 8 different solvent systems using paper and thin layer chromatography, that the substance isolated by Friedhoff from urine of schizophrenics was found to behave exactly as DMPE. Friedhoff (1966) has also used the ultraviolet spectrum of the purified material, the melting point of derivatives and gas chromatography of the acid and N-acetyl derivatives to confirm the identity of material isolated from the urine. This comprises the most exhaustive investigation of the identity of this urinary constituent so far reported. At present other investigators are experiencing difficulty in establishing this identity and this work has not been confirmed.
There have now been a number of reports conceming the excretion of DMPE. The results of these investigations are summarized in Table 1 .
The confusion resulting from these reports as to whether or not an abnormal metabolite is associated with schizophrenia seems to be explicable in terms of: (1) The criteria set by different workers to define the 'DMPE-like' substance.
(2) The variability in the clinical condition of the patients studied.
(3) The techniques employed for isolation and detection (with due regard to the properties of volatility and partition coefficient).
In 1965 Bourdillon et al. reported the results of a survey comprising more than 800 urine samples obtained from schizophrenic patients, mentally ill but not schizophrenic patients, and mentally normal individuals. The greater part of this work was carried out in the form of doubleblind surveys. These workers used the technique of Friedhoff & Van Winkle and a modification of it. Their findings were reported in terms of 'pink spot' rather than DMPE because, although the pink spot which they isolated had chromatographic properties identical with DMPE, further proof would be necessary to make a definite identification. By definition, therefore, pink spot is identical with DMPE in its behaviour on paper chromatography. In these experiments, other pink staining materials were always reported as pink spot negative when they did not fulfil the requirements of the definition. Indeterminate results were reported as impossible to assess. The overall results of these investigations are given in Table 2 . The results show a statistically significant association between pink spot and schizophrenia and particularly those schizophrenics who were acutely disturbed and who were not diagnosed as paranoid schizophrenics. It has not been possible to explain the findings in terms of factors such as diet, bacteria or drugs (Bourdillon & Ridges 1966) , although artifacts due to these have frequently proved to be the explanation of apparent biochemical abnormalities in schizophrenia.
Since our original report, longitudinal studies have shown that pink spot status is variable and goes through both positive and negative phases which apparently bear some relation to the disease process. We have evidence that phenothiazine therapy is associated with a decline in pink spot excretion as the patient responds to treatment. The excretion of pink spot persisted for some time in a patient who failed to respond to therapy. At present we do not know whether or not all schizophrenics excrete pink spot at some time during the course of their disease. We have found no indication that pink spot status materially affects the length of time in hospital or the number of readmissions (Price et al. 1966 ).
If pink spot is a genuine abnormality, the possibilities have to be considered that it develops as a result of the disease or from the excessive production of a normal metabolite and also that it may be a manifestation of a more generalized disturbance in the metabolism of methylated compounds. Its possible use as a genetic marker has been investigated but to date we have not been able to demonstrate that it plays this role; the presence of pink spot neither assists in the early diagnosis of the condition nor indicates a particular type of therapy.
At a time when pink spot is still very much of an enigma, it is interesting to note that other workers (Bergen 1965) have provided evidence that in schizophrenia a protein fraction may be associated with a dialysable molecule similar to DMPE.
We conclude, by reiterating Kety (1966) , that 'although many alternative explanations have not been ruled out, the hypothesis that an alteration in biological transmethylation plays a significant role in some forms of schizophrenia remains a plausible and parsimonious explanation of a fairly diverse range of observations'.
